UK Biobank failures expose drawbacks of sharing genetic and medical records

- Advertisement -

The promise of secure custodianship has failed 198 times over the past 11 months. The volunteers who signed up two decades ago (in 2006) cannot take their DNA back.

Alibaba listed the genetic sequences, medical scans, and lifestyle records of half a million British volunteers for sale for days. This was before anyone at UK Biobank noticed it.

3 academic institutions, since banned from the platform, had quietly walked the data out through a research system. It was meant to be kept under lock -and- key.

At least 1 of the 3 Alibaba listings appeared to contain the full dataset. This covered every one of the 500,000 participants who had confidently handed over their blood, DNA, & decades of personal health information. It was understood that it would be used for medical research.

UK Biobank failures expose drawbacks of sharing genetic and medical records

The UK government confirmed the breach on Thursday, 23 April ’26. Technology minister Ian Murray shared with the House of Commons that Biobank had flagged the incident on Monday, 20 April ’26. The Chinese government and Alibaba collaborated to pull the listings down before any purchases materialised. Murray thanked Beijing directly for its ‘speed & seriousness’ in taking down the data. Given that the three research institutions identified as the source are Chinese, this statement holds significant weight. Officials have, however, declined to draw conclusions about the intent.

Professor Rory Collins, Biobank’s chief executive & principal investigator, had issued a statement saying that the listings had been swiftly removed before any purchases had been initiated. Collins apologised to the participants. He confirmed that access to the research platform had been suspended. This was done while the organization installed file size limits designed to stop researchers from accessing bulk datasets.

An automated checking system to vet outgoing files is not expected to be ready until late this year.

The sales listing isn’t the scandal. Instead, the scandal is what the sales listing reveals about how often the biobank’s data had already been exposed to and where it may now sit.

Roshan Abayasekara
Roshan Abayasekara
Was seconded by Sri Lankan blue chip conglomerate - John Keells Holdings (JKH) to its fully owned subsidiary - Mackinnon Mackenzie Shipping (MMS) in 1995 as a Junior Executive. MMS, in turn, allocated Roshan to its then principal, P&O Containers regional office for container management in the South Asia region. P&O Containers employed British representatives whom Roshan then understudied. During the ‘90s, Roshan relocated to Dubai, UAE, where Roshan specialised in logistics. More recently, Roshan acquired a Merit award in a postgraduate diploma in Business Administration from the University of Northampton, UK.

Hot this week

Breakthrough Could Make Ammonia a More Efficient Carrier for Clean Hydrogen

Science & Technology (Commonwealth Union) – Hydrogen in its...

Egypt’s $51.4 Billion Export Leap: Is the UAE Becoming Its Gateway to the World?

CAIRO, September 14, 2026 — Egypt may have started...

East Africa Braces for Growing Food-Security Pressures as El Niño Threatens Crops

East Africa is at present undergoing a food-security threat...

UK Economy Surges as AI Boom Offers New Hope for Growth

July expansion beats expectations as technology, services and consumer...

PETA Protest at New York Fashion Week Sparks Debate Over Wool and Animal Welfare

New York Fashion Week, which took place recently, was...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories